Investing.com India

ProPhase Labs stock soars after announcing reverse merger with ABL

Investing.com -- ProPhase Labs Inc (NASDAQ:PRPH) stock surged 75.2% in premarket trading Friday after the company announced a ...
Business Insider

ProPhase Labs, Inc. Announces Commencement of Tender Offer to Repurchase Up to 1.7 Million Shares of Its Common Stock at Price of $2.30 Per Share

DOYLESTOWN, Pa., Nov. 20, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (www.ProPhaseLabs.com), a diversified natural health medical science company (the “Company” or “ProPhase”), today ...
Nasdaq

ProPhase Labs, Inc. (PRPH) Soars 11.2%: Is Further Upside Left in the Stock?

ProPhase Labs, Inc. PRPH shares soared 11.2% in the last trading session to close at $8.13. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...
Business Insider

ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET.

ProPhase Labs in discussions for strategic initiative to realize significant underlying value in the Company. Voting for Current Proxy Critically Important. Crown Medical Achieves Final Hurdle.
Nasdaq

ProPhase Labs, Inc. CEO Ted Karkus to Present at Q1 Investor Summit Virtual on March 11th

ProPhase Labs, Inc. announced that CEO Ted Karkus will present at the upcoming Investor Summit Virtual on March 11, 2025, at 1:30 P.M. ET, offering investors insights into the company's operations and ...
Investing

ProPhase Labs stock hits 52-week low at $2.02

In a challenging market environment, ProPhase Labs, Inc. (PRPH) stock has touched a 52-week low, dipping to $2.02. This price level reflects a significant downturn for the company, which has seen its ...